Literature DB >> 7756054

Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.

B D Baumann1, T J Wronski.   

Abstract

The purpose of this study was to determine whether PTH has anabolic effects on cortical bone in aged ovariectomized (OVX) rats treated during the late stages of estrogen depletion. Groups of OVX rats were untreated for 1 year postovariectomy followed by treatment for 10 weeks with vehicle, estrogen, the bisphosphonate risedronate (NE-58095), calcitonin (CT), PTH, PTH + estrogen, PTH + NE-58095 or PTH+CT. A group of sham-operated control rats was treated with vehicle alone. Cross-sections of the tibial diaphysis immediately proximal to the tibiofibular junction were subjected to quantitative bone histomorphometry. In comparison to vehicle-treated control rats, the following structural changes were detected in cortical bone of vehicle-treated OVX rats: increased cortical bone tissue area, increased bone marrow area and a significant decrease in cortical width. Indices of endocortical bone formation were also significantly increased in vehicle-treated OVX rats relative to vehicle-treated control rats. Treatment with the antiresorptive agents estrogen, NE-58095 or CT prevented the decrease in cortical width in OVX rats, but failed to increase cortical bone area. In comparison to vehicle treatment of OVX rats, estrogen and CT decreased both periosteal and endocortical bone formation, whereas NE-58095 decreased endocortical, but not periosteal, bone formation. In contrast, treatment of OVX rats with PTH alone increased cortical bone area and width as well as decreased bone marrow area compared to vehicle treatment of OVX rats. The PTH-induced increase in cortical bone mass was associated with a marked increase in periosteal and endocortical bone formation. Concurrent treatment of OVX rats with PTH+estrogen, PTH + NE-58095 or PTH + CT did not have a greater anabolic effect on cortical bone than treatment with PTH alone. The results indicate that PTH, in contrast to estrogen, NE-58095 and CT, stimulates cortical bone formation and augments cortical bone mass in the tibial diaphysis of aged OVX rats. Therefore, cortical bone of aged OVX rats retains its ability to respond anabolically to PTH even during the late stages of estrogen depletion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756054     DOI: 10.1016/8756-3282(94)00036-y

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.

Authors:  Maria-Grazia Ascenzi; Vivian P Liao; Brittany M Lee; Fabrizio Billi; Hua Zhou; Robert Lindsay; Felicia Cosman; Jeri Nieves; John P Bilezikian; David W Dempster
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

2.  Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.

Authors:  D J Kubek; D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2010-11       Impact factor: 1.826

3.  Old age causes de novo intracortical bone remodeling and porosity in mice.

Authors:  Marilina Piemontese; Maria Almeida; Alexander G Robling; Ha-Neui Kim; Jinhu Xiong; Jeff D Thostenson; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien; Robert L Jilka
Journal:  JCI Insight       Date:  2017-09-07

4.  Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.

Authors:  M Gowen; G B Stroup; R A Dodds; I E James; B J Votta; B R Smith; P K Bhatnagar; A M Lago; J F Callahan; E G DelMar; M A Miller; E F Nemeth; J Fox
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.

Authors:  Joel S Finkelstein; Jason J Wyland; Hang Lee; Robert M Neer
Journal:  J Clin Endocrinol Metab       Date:  2010-02-17       Impact factor: 5.958

6.  Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats.

Authors:  Masafumi Kashii; Jun Hashimoto; Takayoshi Nakano; Yukichi Umakoshi; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

7.  Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.

Authors:  Sarah K Amugongo; Wei Yao; Junjing Jia; Weiwei Dai; Yu-An E Lay; Li Jiang; Danielle Harvey; Elizabeth A Zimmermann; Eric Schaible; Neil Dave; Robert O Ritchie; Donald B Kimmel; Nancy E Lane
Journal:  Bone       Date:  2014-07-10       Impact factor: 4.398

8.  Additive Effects of Mechanical Marrow Ablation and PTH Treatment on de Novo Bone Formation in Mature Adult Rats.

Authors:  Qing Zhang; Christopher Miller; Jesse Bible; Jiliang Li; Xiaoqing Xu; Nozer Mehta; James Gilligan; Agnès Vignery; Jodi A Carlson Scholz
Journal:  Cells       Date:  2012-12-05       Impact factor: 6.600

9.  Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT.

Authors:  J E M Brouwers; B van Rietbergen; R Huiskes; K Ito
Journal:  Osteoporos Int       Date:  2009-03-05       Impact factor: 4.507

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.